Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials
- PMID: 34081332
- PMCID: PMC8242664
- DOI: 10.1002/jmv.27129
Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials
Keywords: COVID-19; Guillain-Barres syndrome; SARS-CoV-2; nerve conduction; neuropathy.
Comment in
-
Response to Finsterer on the letter to the editor "Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials".J Med Virol. 2022 Oct;94(10):4595-4596. doi: 10.1002/jmv.27960. Epub 2022 Jul 2. J Med Virol. 2022. PMID: 35761161 Free PMC article. No abstract available.
Comment on
-
Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.J Med Virol. 2021 Sep;93(9):5599-5602. doi: 10.1002/jmv.27018. Epub 2021 Apr 23. J Med Virol. 2021. PMID: 33851741 Free PMC article.
References
-
- Finsterer J, Scorza FA. Neuropathy of peripheral nerves in COVID‐19 is due to pre‐existing risk factors, anti‐viral drugs, or bedding on the ICU. J Peripher Nerv Syst. 2021. - PubMed
-
- Mah Ming JB, Gill MJ. Drug‐induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. AIDS Patient Care STDS. 2003;17:207‐210. - PubMed
-
- Pradhan S, Pardasani V, Ramteke K. Azithromycin‐induced myasthenic crisis: reversibility with calcium gluconate. Neurol India. 2009;57:352‐353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
